Development and Validation of an In-House Real-Time Reverse-Transcriptase Polymerase Chain Reaction Assay for SARS-CoV-2 Omicron Lineage Subtyping between BA.1 and BA.2
In order to rapidly differentiate sublineages BA.1 and BA.2 of the SARS-CoV-2 variant of concern Omicron, we developed a real-time reverse-transcriptase polymerase chain reaction to target the discriminatory spike protein deletion at amino acid position 69–70 (S:del69–70). Compared to the gold stand...
Main Authors: | David Pham, Susan Maddocks, Dominic E. Dwyer, Vitali Sintchenko, Jen Kok, Rebecca J. Rockett |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/8/1760 |
Similar Items
-
Emergence of omicron variant's sublineages BA.4 and BA.5: risks assessment and possible countermeasures
by: Manish Dhawan, et al.
Published: (2022-07-01) -
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort study
by: Nicolas de Prost, et al.
Published: (2023-08-01) -
The Epidemiological Features of the SARS-CoV-2 Omicron Subvariant BA.5 and Its Evasion of the Neutralizing Activity of Vaccination and Prior Infection
by: Dandan Tian, et al.
Published: (2022-10-01) -
Continued Complexity of Mutations in Omicron Sublineages
by: Austin N. Spratt, et al.
Published: (2022-10-01) -
Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages
by: Li Guo, et al.
Published: (2023-12-01)